Cidara Therapeutics, Inc.
CDTX
株式のランク
#3183
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
株価
$221.38
最終同期: 2026-01-08
時価総額
$5.61B
変化（1日）
0.00%
変化（1年）
118.07%
国
US
取引 Cidara Therapeutics, Inc. (CDTX)
カテゴリー
Healthcare
Cidara Therapeutics, Inc.（CDTX）の営業利益率
October 2026 時点の営業利益率 TTM: 0.00%
Cidara Therapeutics, Inc. の最新の財務報告と株価によると、現在の営業利益率（TTM）は 0.00% です。2023 年末時点では -38.31% でした。
Cidara Therapeutics, Inc. の営業利益率の履歴（2012 から 2026）
各年末の営業利益率
| 年 | 営業利益率 | 変化 |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2024 | -13,811.92% | 35,953.04% |
| 2023 | -38.31% | -26.48% |
| 2022 | -52.11% | -38.87% |
| 2021 | -85.24% | -85.68% |
| 2020 | -595.42% | 198.47% |
| 2019 | -199.49% | 0.00% |
| 2018 | 0.00% | 0.00% |
| 2017 | 0.00% | 0.00% |
| 2016 | 0.00% | 0.00% |
| 2015 | 0.00% | 0.00% |
| 2014 | 0.00% | 0.00% |
| 2013 | 0.00% | 0.00% |
| 2012 | 0.00% | 0.00% |
同業他社の営業利益率
| 企業 | 営業利益率 | 営業利益率の差 | 国 |
|---|---|---|---|
| 38.59% | - |
US
|
|
| -149.01% | - |
US
|
|
| 25.57% | - |
AU
|
|
| 0.00% | - |
CH
|
|
| 28.81% | - |
NL
|
企業の営業利益率とは？
営業利益率は、企業の収益性を評価するための重要な指標です。高い営業利益率は一般的に良いとされており、企業が製品やサービスをその生産コストよりもはるかに高く販売できていることを示します。営業利益率は、企業の利益を売上高で割ることで計算されます。